People paying privately for weight-loss drug Mounjaro in the UK face a rise in the cost of the treatment after manufacturer ...

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

Weight-loss drugs significantly improve health, though they’re also tied to increased spending on other medical care that’s ...

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...

Swiss generic drug manufacturer Sandoz plans to launch unbranded weight-loss drugs in Canada at discounts of up to 70% compared to branded versions once patents begin to expire next year, CEO Richard ...

More than half of large employers plan to scale back health care benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new survey released by ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.

How to find out if weight loss drugs are covered by your insurance, and what to do if they're not Ozempic (semaglutide), Victoza (liraglutide), and Wegovy (semaglutide) are popular medications ...

Insurance coverage for GLP-1 agonists when used for weight loss varies widely, explains GoodRX, a platform for medication savings. But these medications are often covered when prescribed for their ...

rising prices are forcing a rethink: "Some employers facing big cost increases in 2026 may feel this coverage is out of reach," Fluno said. Greater competition in the weight-loss drug market in coming ...

Shareholder sues Hims & Hers board over failed weight-loss drug partnership deal.